Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Integrated platform for care and resarch in diabetes type 2 and prediabetes

Reference number
Coordinator Karolinska Institutet - Institutionen för molekylär medicin och kirurgi
Funding from Vinnova SEK 675 000
Project duration December 2016 - May 2019
Status Completed
Venture The strategic innovation programme, SWElife
Call SWElife Call in Diabetics 2016

Purpose and goal

The main objective is to develop an IT-tool to follow-up on outcomes and costs of the care of type 2 diabetes patients and for people with prediabetes, and further to carry out two pilot studies. The IT-tool is developed and volume tested on synthetic data. Methodology for calculating potential for savings in the prevention of typ 2-diabetes has been developed (Encl. 1). A pilot study is in progress and will be completed during autumn 2019. In this study, patients share data on their own care with their care provider (Encl. 2), that appears to increase study adherence.

Expected results and effects

The IT tool, configured in Microsoft´s services (Azure), contains a data warehouse that structures health care information in concert with the diabetes template in Stockholm County Council´s (SLL´s) record system Take Care (TC) and a standardized care proc structured analysis of completed care (Encl. 3). The IT tool has been further developed within another SweLife project (Dnr 2017-05319) with machine learning algorithms for analysis of factors increasing or decreasing diabetes risk.

Planned approach and implementation

Our studies have shown that a good function for patient consent is available in TC, why we have chosen not to develop a new system for this purpose. A novel IT platform for analysis of big data volumes has been developed and shown to be useful. It is very likely to be applicable also in other contexts/studies. The app MittDiacert is useful in an intervention in T2D patients (PI Y Trolle Lagerros, SLL). It has been shown to enhance study adherence. This or similar app may be applied in other intervention studies.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 26 February 2019

Reference number 2016-04219

Page statistics